-
-
-
-
-
-
-
OSE Immunotherapeutics Announces H1 2021 ResultsĀ and Provides a Corporate Update
-
-
-
-
-
-
-
OSE Immunotherapeutics Reports First Half 2019 Results and Provides a Corporate Update
-
-
-
-
-
-
-
OSE Immunotherapeutics: 2017 Annual Results and Clinical Advances of its Proprietary and Partnered Products
-
-
-
-
-
-
973,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All